SPOTLIGHT: Sonus lays off workers in restructuring


Sonus Pharmaceuticals is laying off 16 workers and stopping work on two oncology programs so it can focus its resources on its early-stage drug SN2310 while exploring in-licensing opportunities and strategic transactions. Release

Suggested Articles

Almirall and Iktos will use the latter's AI technology to design new compounds that tick multiple drug criteria boxes.

Pfizer’s 2017 spinout company SpringWorks has lost president and founder Lara Sullivan, M.D., who has moved over to Pyxis Oncology as its new chief.

In this week's EuroBiotech Report, Sanofi inks $2.5B Synthorx takeover and posts sutimlimab data, Roche shares bispecific results and more.